US Bancorp
KURA icon

US Bancorp’s Kura Oncology KURA Stock Holding History

US Bancorp’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.68K Sell
518
-3,814
-88% -$36K ﹤0.01% 3620
2026
Q1 		$35.2K Buy
4,332
+257
+6% +$2.21K ﹤0.01% 2853
2025
Q4 		$42.3K Buy
4,075
+3,701
+990% +$38.8K ﹤0.01% 2770
2025
Q3 		$3.31K Sell
374
-35,430
-99% -$253K ﹤0.01% 3651
2025
Q2 		$207K Sell
35,804
-3,823
-10% -$23.4K ﹤0.01% 1998
2025
Q1 		$262K Buy
39,627
+17,523
+79% +$137K ﹤0.01% 1857
2024
Q4 		$193K Buy
22,104
+14,335
+185% +$206K ﹤0.01% 2045
2024
Q3 		$152K Sell
7,769
-1,410
-15% -$28.6K ﹤0.01% 2181
2024
Q2 		$189K Buy
9,179
+543
+6% +$11.2K ﹤0.01% 2034
2024
Q1 		$184K Buy
8,636
+6,539
+312% +$127K ﹤0.01% 2052
2023
Q4 		$30.2K Buy
2,097
+651
+45% +$6.4K ﹤0.01% 2889
2023
Q3 		$13.2K Buy
1,446
+354
+32% +$3.59K ﹤0.01% 3064
2023
Q2 		$11.6K Buy
1,092
+207
+23% +$2.45K ﹤0.01% 3210
2023
Q1 		$10.8K Sell
885
-736
-45% -$9.18K ﹤0.01% 3252
2022
Q4 		$20.1K Buy
1,621
+177
+12% +$2.57K ﹤0.01% 2986
2022
Q3 		$20K Buy
1,444
+1,310
+978% +$20.2K ﹤0.01% 3015
2022
Q2 		$2K Sell
134
-480
-78% -$6.91K ﹤0.01% 3845
2022
Q1 		$10K Buy
+614
New +$8.87K ﹤0.01% 3371
2021
Q4 		– Sell
-847
Closed -$16K – 4173
2021
Q3 		$16K Buy
847
+547
+182% +$10.3K ﹤0.01% 3234
2021
Q2 		$7K Buy
300
+284
+1,775% +$7.05K ﹤0.01% 3522
2021
Q1 		$0 Sell
16
-61
-79% -$1.93K ﹤0.01% 3924
2020
Q4 		$3K Buy
+77
New +$2.71K ﹤0.01% 3505

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

US Bancorp's KURA Position: Q2 2026 in Review

US Bancorp reduced its Kura Oncology (KURA) stake by 88% in Q2 2026, selling an estimated $36K and leaving 518 shares worth $5.68K. The position accounts for ﹤0.01% of the portfolio, ranked #3620.

US Bancorp first reported a position in KURA in Q4 2020 and has held it in 22 quarters since. The position peaked at $262K in Q1 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • US Bancorp held 518 shares of Kura Oncology worth $5.68K as of Q2 2026.
  • US Bancorp sold 3,814 Kura Oncology shares in Q2 2026, an estimated $36K.
  • Kura Oncology made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3620 holding.
  • US Bancorp first reported a position in Kura Oncology in Q4 2020 and has held it in 22 quarters since.
  • US Bancorp's Kura Oncology position peaked at $262K in Q1 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.